These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 28144802)

  • 1. Treatment of Elderly Patients With Acute Myeloid Leukemia.
    Thomas X; Le Jeune C
    Curr Treat Options Oncol; 2017 Jan; 18(1):2. PubMed ID: 28144802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conventional chemotherapy or hypomethylating agents for older patients with acute myeloid leukaemia?
    Ferrara F
    Hematol Oncol; 2014 Mar; 32(1):1-9. PubMed ID: 23512815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging strategies for the treatment of older patients with acute myeloid leukemia.
    Sanz MA; Iacoboni G; Montesinos P; Venditti A
    Ann Hematol; 2016 Oct; 95(10):1583-93. PubMed ID: 27118541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Relapsed/Refractory Acute Myeloid Leukemia.
    Bose P; Vachhani P; Cortes JE
    Curr Treat Options Oncol; 2017 Mar; 18(3):17. PubMed ID: 28286924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic decision-making in elderly patients with acute myeloid leukemia: conventional intensive chemotherapy versus hypomethylating agent therapy.
    Oh SB; Park SW; Chung JS; Lee WS; Lee HS; Cho SH; Choi YS; Lim SN; Shin HJ;
    Ann Hematol; 2017 Nov; 96(11):1801-1809. PubMed ID: 28828639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The management and treatment of acute leukemias in the elderly population.
    Thomas X
    Expert Rev Hematol; 2017 Nov; 10(11):975-985. PubMed ID: 28931310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute myeloid leukemia in the elderly: therapeutic options and choice.
    Webster JA; Pratz KW
    Leuk Lymphoma; 2018 Feb; 59(2):274-287. PubMed ID: 28573892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial therapy for acute myeloid leukemia in older patients: principles of care.
    Bhatt VR; Gundabolu K; Koll T; Maness LJ
    Leuk Lymphoma; 2018 Jan; 59(1):29-41. PubMed ID: 28573900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Future prospects of therapeutic clinical trials in acute myeloid leukemia.
    Khan M; Mansoor AE; Kadia TM
    Future Oncol; 2017 Mar; 13(6):523-535. PubMed ID: 27771959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Evaluation of Treatment Patterns and Outcomes in Elderly Patients Newly Diagnosed With Acute Myeloid Leukemia: A Retrospective Analysis of Electronic Medical Records From US Community Oncology Practices.
    Ma E; Bonthapally V; Chawla A; Lefebvre P; Swords R; Lafeuille MH; Fortier J; Emond B; Duh MS; Dezube BJ
    Clin Lymphoma Myeloma Leuk; 2016 Nov; 16(11):625-636.e3. PubMed ID: 27686689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of TP53 is associated with poor survival, but not with reduced response to hypomethylating agents in older patients with acute myeloid leukaemia.
    van der Helm LH; Berger G; Diepstra A; Huls G; Vellenga E
    Br J Haematol; 2017 Sep; 178(5):810-812. PubMed ID: 27431572
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute myeloid leukemia: advancing clinical trials and promising therapeutics.
    Daver N; Cortes J; Kantarjian H; Ravandi F
    Expert Rev Hematol; 2016 May; 9(5):433-45. PubMed ID: 26910051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Panobinostat for the treatment of acute myelogenous leukemia.
    Morabito F; Voso MT; Hohaus S; Gentile M; Vigna E; Recchia AG; Iovino L; Benedetti E; Lo-Coco F; Galimberti S
    Expert Opin Investig Drugs; 2016 Sep; 25(9):1117-31. PubMed ID: 27485472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute myeloid Leukemia].
    Braess J
    Dtsch Med Wochenschr; 2016 Nov; 141(24):1748-1751. PubMed ID: 27835920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elderly Patients (Age 70 Years or Older) With Secondary Acute Myeloid Leukemia or Acute Myeloid Leukemia Developed Concurrently to Another Malignant Disease.
    Collinge E; Loron S; Larcher MV; Elhamri M; Heiblig M; Deloire A; Ducastelle S; Labussière H; Barraco F; Wattel E; Salles G; Paubelle E; Thomas X
    Clin Lymphoma Myeloma Leuk; 2018 May; 18(5):e211-e218. PubMed ID: 29572159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of primary refractory acute myeloid leukemia in the era of targeted therapies.
    McMahon CM; Perl AE
    Leuk Lymphoma; 2019 Mar; 60(3):583-597. PubMed ID: 30234399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging therapeutic modalities for acute myeloid leukemia (AML) in older adults.
    Huang LW; Olin RL
    J Geriatr Oncol; 2017 Nov; 8(6):417-420. PubMed ID: 28835351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment patterns and comparative effectiveness in elderly acute myeloid leukemia patients (age 70 years or older): the Lyon-university hospital experience.
    Heiblig M; Le Jeune C; Elhamri M; Balsat M; Tigaud I; Plesa A; Barraco F; Labussière H; Ducastelle S; Nicolini F; Wattel E; Salles G; Thomas X
    Leuk Lymphoma; 2017 Jan; 58(1):110-117. PubMed ID: 27184036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute leukemia in adults].
    Eigendorff E; Hochhaus A
    Pathologe; 2015 Sep; 36(5):503-17; quiz 518-9. PubMed ID: 26314268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted anti-leukemic therapy as disease-stabilizing treatment for acute myeloid leukemia relapse after allogeneic stem cell transplantation: Will it be possible to combine these strategies with retransplantation or donor lymphocyte infusions?
    Reikvam H; Kittang AO; Melve G; Mosevoll KA; Bentsen PT; Ersvær E; Gjertsen BT; Bruserud Ø
    Curr Cancer Drug Targets; 2013 Jan; 13(1):30-47. PubMed ID: 22873213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.